{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P36956",
      "entity_text" : "SREBP-1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR Of note, SREBP-1 is stimulated by insulin; thus, the inhibition of SREBP-1 by n-3 LC-PUFAs is of particular importance in patients with NAFLD, as they are often also affected by hyperinsulinemia and insulin resistance and are thus predisposed to insulin induced stimulation of SREBP-1 and, consequently, the synthesis and accumulation of liver fatty acids.",
  "reading_complete" : "2020-08-02T09:41:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T09:38:07Z",
  "trigger" : "stimulated",
  "evidence" : [ "SREBP-1 is stimulated by insulin" ],
  "pmc_id" : "6367993",
  "score" : 0
}